Literature DB >> 2644898

Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study.

J L Gouzi1, M Huguier, P L Fagniez, B Launois, Y Flamant, F Lacaine, J C Paquet, J M Hay.   

Abstract

In a multicentric trial the postoperative mortality and the 5-year survival of elective total gastrectomy (TG) was compared with subtotal gastrectomy (SG) for adenocarcinoma of the antrum operated on with intent of cure. Two hundred and one patients were included in the study; 32 were excluded after pathologic examination (linitis plastica, superficial cancer, lymphoma). One hundred sixty-nine patients remained for analysis, with 93 undergoing TG and 76 undergoing SG. Elective TG did not increase postoperative mortality (1.3%) compared with SG (3.2%). There was no difference in the 5-year survival rate (48%). Analysis of survival showed no difference in the two techniques when related to nodal involvement and serosal extension. It is concluded that both TG and SG can be performed safely in patients with adenocarcinoma of the antrum; however TG did not increase the survival rate.

Entities:  

Mesh:

Year:  1989        PMID: 2644898      PMCID: PMC1493901          DOI: 10.1097/00000658-198902000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  18 in total

1.  [Value of total gastrectomy for treatment of cancers of the stomach. Study of 482 radical operations].

Authors:  J Lortat-Jacob; R Giuli; B Estenne; P Clot
Journal:  Chirurgie       Date:  1975 Jan 15-29

2.  Gastric carcinoma: a multicentric lesion.

Authors:  W T COLLINS; E A GALL
Journal:  Cancer       Date:  1952-01       Impact factor: 6.860

3.  An analysis of twenty years' experience with operations for carcinoma of the stomach.

Authors:  R R White; J A Mackie; W T Fitts
Journal:  Ann Surg       Date:  1975-05       Impact factor: 12.969

4.  Results of treatment of stomach cancer. An appraisal of efforts for more extensive surgery and a rort of 1,983 cases.

Authors:  V A Gilbertsen
Journal:  Cancer       Date:  1969-06       Impact factor: 6.860

5.  Cancer of the stomach. Review of consecutive ten year intervals.

Authors:  K Adashek; J Sanger; W P Longmire
Journal:  Ann Surg       Date:  1979-01       Impact factor: 12.969

6.  [Carcinoma of the stomach. Resectability and survival rates in 408 operated patients (author's transl)].

Authors:  J Moreaux; P Montupet
Journal:  Nouv Presse Med       Date:  1981-10-24

7.  Selection of operative procedure for adenocarcinoma of the midstomach. Twenty years' experience with implications for future treatment strategy.

Authors:  M H Shiu; D N Papacristou; C Kosloff; G Eliopoulos
Journal:  Ann Surg       Date:  1980-12       Impact factor: 12.969

8.  Clinical correlates of resectability and survival in gastric carcinoma.

Authors:  T W Buchholtz; C E Welch; R A Malt
Journal:  Ann Surg       Date:  1978-12       Impact factor: 12.969

9.  [Carcinoma of the stomach. Factors relating to survival (author's transl)].

Authors:  M Huguier; F Lacaine
Journal:  Nouv Presse Med       Date:  1980-01-19

10.  Elective total gastrectomy for cancer of the stomach: end results.

Authors:  G McNeer; L Bowden; R J Booner; C J McPeak
Journal:  Ann Surg       Date:  1974-08       Impact factor: 12.969

View more
  57 in total

Review 1.  Management of upper gastrointestinal cancers.

Authors:  A Melville; E Morris; D Forman; A Eastwood
Journal:  Qual Health Care       Date:  2001-03

2.  Gastric Cancer.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-06

3.  Adenocarcinoma of the stomach: a review of 35 years and 1,710 cases.

Authors:  J R Breaux; W Bringaze; C Chappuis; I Cohn
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

4.  Issues in the management of the upper third gastric cancer.

Authors:  Han-Kwang Yang
Journal:  Cancer Res Treat       Date:  2004-02-29       Impact factor: 4.679

Review 5.  Quality of life: A critical outcome for all surgical treatments of gastric cancer.

Authors:  Michael D McCall; Peter J Graham; Oliver F Bathe
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

6.  Treatment of resectable gastric cancer.

Authors:  Johan L Dikken; Cornelis J H van de Velde; Daniel G Coit; Manish A Shah; Marcel Verheij; Annemieke Cats
Journal:  Therap Adv Gastroenterol       Date:  2012-01       Impact factor: 4.409

Review 7.  Current management of gastric cancer.

Authors:  Ulf H Haglund; Bengt Wallner
Journal:  J Gastrointest Surg       Date:  2004-11       Impact factor: 3.452

8.  Risk factors related to operative morbidity in patients undergoing gastrectomy for gastric cancer.

Authors:  A Gil-Rendo; J L Hernández-Lizoain; F Martínez-Regueira; A Sierra Martínez; F Rotellar Sastre; M Cervera Delgado; V Valentí Azcarate; C Pastor Idoate; J Alvarez-Cienfuegos
Journal:  Clin Transl Oncol       Date:  2006-05       Impact factor: 3.405

Review 9.  Treatment of gastric cancer.

Authors:  Michele Orditura; Gennaro Galizia; Vincenzo Sforza; Valentina Gambardella; Alessio Fabozzi; Maria Maddalena Laterza; Francesca Andreozzi; Jole Ventriglia; Beatrice Savastano; Andrea Mabilia; Eva Lieto; Fortunato Ciardiello; Ferdinando De Vita
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

10.  Perspectives of surgery and multimodality treatment in gastric carcinoma.

Authors:  H J Meyer; J Jähne; H Wilke
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.